BNTX BioNTech SE Stock Quote

BNTX [NASD]

Index	-	P/E	-	EPS (ttm)	-	Insider Own	1.18%	Shs Outstand	238.67M	Perf Week	-3.83%
Market Cap	27.34B	Forward P/E	6.15	EPS next Y	17.91	Insider Trans	0.00%	Shs Float	223.06M	Perf Month	0.19%
Income	-	PEG	-	EPS next Q	-0.19	Inst Own	9.60%	Short Float	1.66%	Perf Quarter	5.00%
Sales	-	P/S	-	EPS this Y	-300.50%	Inst Trans	-8.28%	Short Ratio	1.24	Perf Half Y	68.03%
Book/sh	4.73	P/B	23.30	EPS next Y	1056.10%	ROA	-	Target Price	120.20	Perf Year	213.99%
Cash/sh	4.95	P/C	22.27	EPS next 5Y	-	ROE	-	52W Range	28.00 - 131.00	Perf YTD	35.19%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-32.00%	52W High	-18.50%	Beta	-
Dividend %	-	Quick Ratio	4.00	Sales past 5Y	-	Gross Margin	-	52W Low	281.30%	ATR	5.20
Employees	1800	Current Ratio	4.10	Sales Q/Q	30.10%	Oper. Margin	-	RSI (14)	41.98	Volatility	4.94% 4.27%
Optionable	Yes	Debt/Eq	0.34	EPS Q/Q	-119.50%	Profit Margin	-	Rel Volume	0.32	Prev Close	110.21
Shortable	Yes	LT Debt/Eq	0.19	Earnings	-	Payout	-	Avg Volume	2.98M	Price	106.76
Recom	2.20	SMA20	-7.34%	SMA50	0.33%	SMA200	26.63%	Volume	453,349	Change	-3.13%

Dec-01-20

Downgrade

BofA Securities

Buy → Neutral

$123 → $126

Aug-03-20

Resumed

Berenberg

Buy

$98

Jul-21-20

Upgrade

BofA Securities

Neutral → Buy

$71 → $105

Jun-30-20

Downgrade

H.C. Wainwright

Buy → Neutral

May-19-20

Upgrade

H.C. Wainwright

Neutral → Buy

$48 → $69

Apr-28-20

Downgrade

BofA/Merrill

Buy → Neutral

$46 → $51

Mar-18-20

Downgrade

JP Morgan

Overweight → Neutral

$23 → $33

Mar-09-20

Initiated

H.C. Wainwright

Neutral

$30

Jan-24-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

Jan-22-20

Downgrade

UBS

Buy → Neutral

$35

Nov-05-19

Initiated

Wolfe Research

Outperform

Nov-04-19

Initiated

UBS

Buy

$21

Nov-04-19

Initiated

SVB Leerink

Outperform

Nov-04-19

Initiated

JP Morgan

Overweight

$23

Nov-04-19

Initiated

Canaccord Genuity

Buy

$22

Nov-04-19

Initiated

BofA/Merrill

Buy

$21

Nov-04-19

Initiated

Berenberg

Buy

$25

Mar-02-21 10:32AM	U.S. COVID vaccine supply to be boosted by Merck helping make J&J vaccine MarketWatch
08:18AM	UPDATE 1-France uses only quarter of Astrazeneca vaccine doses-ministry Reuters
07:59AM	Single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospitalization risk by more than 80%, study shows MarketWatch
07:18AM	The Zacks Analyst Blog Highlights: Johnson & Johnson, Pfizer, BioNTech, Moderna and AstraZeneca Zacks
06:05AM	Could Coronavirus Variants Boost Pfizer's Vaccine Sales By 50%? Motley Fool
Mar-01-21 11:15PM	UPDATE 1-Fauci says U.S. must stick to two-shot strategy for Pfizer, Moderna COVID-19 vaccines - paper Reuters
04:18PM	JNJ Stock Rises In Buy Zone As U.S. Begins Distributing Third Covid Vaccine Investor's Business Daily
04:16PM	Vaccine Acceptance Rises As Americans Eye Covid Mutations: IBD/TIPP Poll Investor's Business Daily
12:39PM	J&J CEO: 'We're doing this for the long run' Yahoo Finance
11:07AM	J&J to roll-out single-shot COVID-19 vaccine this week Yahoo Finance Video
10:39AM	Analyzing BioNTech's Unusual Options Activity Benzinga
10:32AM	J&J CEO says Americans should start getting single-dose COVID vaccine within 48 hours MarketWatch
08:54AM	FDA Emergency Nod for J&J COVID-19 Vaccine Heats Up Competition Zacks
07:15AM	South Africa Variant Flummoxes AstraZeneca Vaccine; Is AZN Stock A Buy? Investor's Business Daily
Feb-27-21 08:22PM	FDA Issues Emergency Use Authorization for J&J Covid-19 Vaccine Barrons.com
09:23AM	15 Fastest Growing Biotech Companies in the US Insider Monkey
08:17AM	Johnson & Johnson's Vaccine Gets Unanimous Backing Of FDA Panel, Emergency-Use Authorization Soon To Come Benzinga
Feb-26-21 08:56PM	South Korea vaccinates 18,000 to start ambitious COVID-19 campaign Reuters
07:24PM	The Pandemic Tested Healthcare R&D. Now the Future Looks Bright. Barrons.com
05:38PM	FDA Panel Unanimously Endorses J&J's Covid Vaccine For Emergency Use Investor's Business Daily
05:08PM	FDA committee votes unanimously, says benefits of J&J's COVID-19 vaccine outweigh the risks MarketWatch
05:06PM	J&J single-dose COVID-19 vaccine gets green light from FDA Yahoo Finance
10:37AM	Global COVID cases top 113 million as FDA committee meets to vote on J&J vaccine MarketWatch
07:30AM	Novavax Surges Again On Vaccine Supply Deal; Is NVAX Stock A Buy? Investor's Business Daily
06:30AM	Coronavirus tally: Global cases of COVID-19 top 113 million and U.S. death toll atop 508,000 MarketWatch
06:00AM	YF Spotlight: American educators search for common ground on school reopening Yahoo Finance Video
Feb-25-21 04:52PM	UPDATE 1-FDA allows storage, transport of Pfizer vaccine at higher temperatures Reuters
04:42PM	Pfizer: FDA eases ultra-low temperature requirements for COVID-19 vaccine MarketWatch
12:40PM	Pfizer Will Test Third Dose of Vaccine to Protect Against Variants Barrons.com
10:33AM	Pfizer Vaccine 94% Effective Across Age Groups in Israeli Study Barrons.com
08:10AM	UPDATE 1-Pfizer-BioNTech testing booster of their COVID-19 vaccine in new trial Reuters
08:08AM	The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga
07:39AM	Pfizer-BioNTech testing booster of their COVID-19 vaccine in new trial Reuters
07:03AM	Pfizer-BioNTech Vaccine 94% Effective In Real World: Study Benzinga
07:03AM	Pfizer, BioNTech to test a COVID-19 vaccine booster against new SARS-CoV-2 variants MarketWatch
06:45AM	Pfizer-BioNTech testing booster of their COVID-19 vaccine in new trial Reuters
06:45AM	Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants GlobeNewswire
06:45AM	Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants Business Wire
Feb-24-21 06:06PM	How Pfizer Plans to Combat Covid-19 Variants Barrons.com
04:42PM	Johnson & Johnson Nabs FDA Endorsement For Covid Shot Ahead Of Key Meeting Investor's Business Daily
04:37PM	Moderna Sparks On Plans To Test New Covid Vaccine Against Viral Mutant Investor's Business Daily
04:12PM	Moderna Ships Updated Covid-19 Vaccine to NIH for Testing Barrons.com
04:10PM	Moderna expands vaccine production, sets 2022 target of 1.4B doses Yahoo Finance
10:29AM	Global COVID cases fall for a sixth straight week as hopes for J&J vaccine are bolstered by FDA data MarketWatch
Feb-23-21 03:54PM	COVID-19 vaccine manufacturing is improving, executives tell Congress Yahoo Finance
11:57AM	UPDATE 1-FDA to allow Pfizer-BioNTech vaccine to be stored at higher temps - NYT Reuters
10:55AM	Vaccine Makers Promise More Supply as FDA Clears Path for Faster Updates Barrons.com
10:50AM	Lyft partners with CVS to increase accessibility of the COVID-19 vaccine Yahoo Finance Video
05:51AM	2 Reasons Pfizer's COVID Vaccine Prospects Just Got Even Better Motley Fool
02:49AM	Pfizer's COVID-19 vaccine gets nod in S.Korea from first of three expert panels Reuters
Feb-22-21 04:55PM	U.S. COVID deaths top 500,000 as experts look to FDA meeting on J&Js one-dose vaccine MarketWatch
02:55PM	Doctor: COVID-19 is approaching the second leading cause of death in the U.S. Yahoo Finance Video
07:46AM	FDA committee to review J&J's COVID-19 vaccine candidate on Thursday MarketWatch
07:09AM	Pfizer/BioNtech's COVID-19 Shot Staved Off Illness, Death For Over 95% Of Israeli patients Benzinga
06:07AM	Sanofi, GSK Restart Trials on Covid-19 Vaccine After Delay Bloomberg
05:28AM	Pfizer Expands Production For COVID-19 Doses After Meeting With President: Bloomberg Benzinga
Feb-21-21 09:00AM	Join Us For Barrons Healthcare Investing Roundtable on Feb. 24 Barrons.com
Feb-19-21 07:45PM	Pfizer and BioNTech Coronavirus Vaccine Effective After 1 Dose, Can Last 2 Weeks in Standard Freezer, Separate Research Shows Motley Fool
01:58PM	Fauci says U.S. is sticking to two doses of the BioNTech/Pfizer vaccine MarketWatch
12:48PM	South Africa Variant Flummoxes AstraZeneca Vaccine; Is AZN Stock A Buy? Investor's Business Daily
12:43PM	Novavax Surges Against On Vaccine Supply Deal; Is NVAX Stock A Buy? Investor's Business Daily
12:14PM	Dow Jones Eyes New High As Caterpillar Rallies; Travel Stocks Break Out Investor's Business Daily
12:09PM	UPDATE 1-First month of shots find no safety issues with Pfizer/BioNTech, Moderna vaccines -U.S. data Reuters
10:54AM	Global case tally for COVID climbs above 110.4 million as G-7 gathers to discuss vaccine equity MarketWatch
10:45AM	Pfizer, Seeking Big Sales Of Covid-19 Vaccine, Adds to Its Lead Barrons.com
09:25AM	Turkey to procure 105 mln doses of COVID-19 vaccines by end-April -Sabah Reuters
08:22AM	Mayo Clinic: COVID-19 vaccines are 88.7% effective in the 'real world' MarketWatch
07:37AM	UPDATE 1-Israeli studies find Pfizer COVID-19 vaccine reduces transmission Reuters
07:28AM	BioNTech, Pfizer say their COVID-19 vaccine can be stored at higher temperatures than previously thought MarketWatch
07:07AM	Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA GlobeNewswire
Feb-18-21 06:00PM	Pfizer and BioNTech Launch Coronavirus Vaccine Study for Pregnant Women Motley Fool
04:47PM	Pfizer, BioNTech Begin Global Clinical Study Of COVID-19 Vaccine In Pregnant Women Benzinga
04:26PM	Will The South African Variant Undo Pfizer, Moderna Covid Vaccines? Investor's Business Daily
01:45PM	Pfizer, BioNTech have started trial to evaluate their COVID-19 vaccine in pregnant women MarketWatch
01:30PM	Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women GlobeNewswire
11:08AM	Bill Gates: with vaccine acceptance U.S. will be back to normal by fall Yahoo Finance Video
11:07AM	UN chief joins WHO in slamming rich countries for hogging COVID vaccines MarketWatch
10:52AM	Retractable Technologies gets $54 million to supply syringes to the U.S. for COVID-19 vaccination MarketWatch
09:25AM	Vaccine Boosters for South African Strain Look More Likely to Be Needed Barrons.com
07:26AM	Pfizer Says South African Variant Could Significantly Reduce Vaccine Protection: Reuters Benzinga
04:15AM	UPDATE 1-BioNTech says will provide vaccines to Taiwan, talks ongoing Reuters
Feb-17-21 07:28PM	BioNTech says will provide vaccines to Taiwan, talks ongoing Reuters
05:34PM	Pfizer, BioNTech COVID-19 vaccine likely to protect against South Africa strain MarketWatch
05:13PM	In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations GlobeNewswire
10:46AM	President Joe Biden seeks to assuage concerns about pace of vaccination MarketWatch
09:43AM	Exclusive: Pfizer's COVID-19 vaccine supply to the EU 30% below plans - sources Reuters
09:15AM	Pfizer-BioNTech To Supply Another 200M COVID-19 Vaccine Doses To EU SmarterAnalyst
07:26AM	The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal Benzinga
06:46AM	Exclusive: Pfizer's COVID-19 vaccine supply to the EU 30% below plans, sources say Reuters
06:46AM	Exclusive: Pfizer COVID-19 vaccine supply to the EU about 10 million doses short of plan -sources Reuters
06:20AM	Europe Calls On Pfizer/BioNtech For 200M More COVID-19 Vaccine Doses Benzinga
06:13AM	Taiwan Puts BioNTech Vaccine Deal On Hold Due To Pressure From China: Bloomberg Benzinga
04:00AM	Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY® GlobeNewswire
01:06AM	Taiwan says BioNTech vaccine deal on hold, cites potential Chinese pressure Reuters
Feb-16-21 10:46AM	Winter storm disrupts COVID-19 vaccine program as snow and ice force sites to temporarily close MarketWatch
08:05AM	World Health Organization Authorizes AstraZenecas Covid-19 Vaccine Barrons.com
07:47AM	WHO and Australian approvals lift hopes for AstraZeneca vaccine MarketWatch
Feb-15-21 09:34PM	UPDATE 3-Malaysia to kick off COVID-19 vaccination drive next week Reuters
12:52PM	Welcome home: U.K. arrivals from high-risk countries start checking in at quarantine hotels MarketWatch
Feb-14-21 05:12AM	Sanofis COVID-19 Vaccine With Translate Bio Delayed Until Next Year Report SmarterAnalyst

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in developing FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/II trial for prostate cancer; BNT113, which is in Phase I trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116, which is in preclinical trail for non-small cell lung cancer. It also develops neo-antigen specific immunotherapies, such as RO7198457, which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT152 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT212 for pancreatic and other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II a clinical trial to treat multiple solid tumors. Further, it develops MVT-5873, an IgG1 monoclonal antibody, which is in Phase I/II clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Genevant Sciences GmbH; Eli Lilly and Company; Bayer AG; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; Regeneron Pharmaceuticals, Inc.; and InstaDeep Ltd. The company was founded in 2008 and is headquartered in Mainz, Germany.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience